May 09, 2019 / 09:30AM GMT
Andrea Recordati - Recordati Industria Chimica e Farmaceutica S.p.A. - CEO & Director
I'm going to start as it's 10:31. Welcome. Thank you for coming to participate to the presentation of the global strategy, development strategy of Recordati and the objectives for the 2019 and '21 plan. You obviously already have insight in advance, insights on these numbers because they were released in the press release forming the Board of Directors yesterday. But obviously, the plan today is to give you more color and information on what lies behind this plan, so strategy-wise and the financials and sales functions-wise.
So for those of you who don't know Recordati because I know there are a few of you that don't know the company, I will go to Slide 4, please, Marianne, to give a quick profile of Recordati and what Recordati is today. Recordati is an Italian-originated pharmaceutical company. The company, obviously we closed 2018 with EUR 1.3 billion worth of sales. And we have 4,142 employees across the world. The company has 2 main business units, one is the specialty and primary care business unit,
Q1 2019 Recordati Industria Chimica e Farmaceutica SpA Earnings & 2019-2021 Business Plan Call Transcript
May 09, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers